Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-27 @ 1:33 AM
Study NCT ID:
NCT02966093
Status:
COMPLETED
Last Update Posted:
2022-01-26
First Post:
2016-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China
Sponsor:
Eisai Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-29
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-15
First Submit QC Date:
None
Study First Post Date:
2016-11-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-25
Last Update Post Date:
2022-01-26
Last Update Post Date Type:
ACTUAL